Loading…
Structure activity relationships of quinoline-containing c-Met inhibitors
A series of quinoline-containing c-Met inhibitors were prepared and studied. Chemistry was developed to introduce a pyridyl moiety onto the 2-aryl ring present in a lead molecule which mitigated the potential for quinone formation relative to the original compound. The study also assessed the import...
Saved in:
Published in: | European journal of medicinal chemistry 2008-06, Vol.43 (6), p.1321-1329 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3 |
container_end_page | 1329 |
container_issue | 6 |
container_start_page | 1321 |
container_title | European journal of medicinal chemistry |
container_volume | 43 |
creator | Kung, Pei-Pei Funk, Lee Meng, Jerry Alton, Gordon Padrique, Ellen Mroczkowski, Barbara |
description | A series of quinoline-containing c-Met inhibitors were prepared and studied. Chemistry was developed to introduce a pyridyl moiety onto the 2-aryl ring present in a lead molecule which mitigated the potential for quinone formation relative to the original compound. The study also assessed the importance of an acylthiourea moiety present in the lead structure for effective binding to the c-Met protein ATP site.
[Display omitted] |
doi_str_mv | 10.1016/j.ejmech.2007.08.011 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71617208</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523407003339</els_id><sourcerecordid>71617208</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3</originalsourceid><addsrcrecordid>eNp9kE1rFEEURQtRzCT6D0R6o7tuX333bAQJagIRF-q6qK5-7byhp2pSVR3Iv7fDDLpz9bhw7uVxGHvDoePAzYd9h_sDhl0nAGwHfQecP2Mbbk3fSqHVc7YBIWSrhVQX7LKUPQBoA_CSXXC7NWqNG3b7o-Yl1CVj40OlB6qPTcbZV0qx7OhYmjQ19wvFNFPENqRYPUWKv5vQfsPaUNzRQDXl8oq9mPxc8PX5XrFfXz7_vL5p775_vb3-dNcGuYXa9hYGs1V2UNIMgXvLp34ycrScD0JoEbhFUHY7jbof-oAKQUttufZSWdl7ecXen3aPOd0vWKo7UAk4zz5iWoqz3HAroF9BdQJDTqVknNwx08HnR8fBPSl0e3dS6J4UOujdqnCtvT3vL8MBx3-ls7MVeHcGfAl-nrKPgcpfToDiQmqzch9PHK42HgizK4EwBhwpY6huTPT_T_4A66yQpg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71617208</pqid></control><display><type>article</type><title>Structure activity relationships of quinoline-containing c-Met inhibitors</title><source>ScienceDirect Journals</source><creator>Kung, Pei-Pei ; Funk, Lee ; Meng, Jerry ; Alton, Gordon ; Padrique, Ellen ; Mroczkowski, Barbara</creator><creatorcontrib>Kung, Pei-Pei ; Funk, Lee ; Meng, Jerry ; Alton, Gordon ; Padrique, Ellen ; Mroczkowski, Barbara</creatorcontrib><description>A series of quinoline-containing c-Met inhibitors were prepared and studied. Chemistry was developed to introduce a pyridyl moiety onto the 2-aryl ring present in a lead molecule which mitigated the potential for quinone formation relative to the original compound. The study also assessed the importance of an acylthiourea moiety present in the lead structure for effective binding to the c-Met protein ATP site.
[Display omitted]</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2007.08.011</identifier><identifier>PMID: 17964000</identifier><identifier>CODEN: EJMCA5</identifier><language>eng</language><publisher>Oxford: Elsevier Masson SAS</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; c-Met ; General aspects ; Magnetic Resonance Spectroscopy ; Mass Spectrometry ; Medical sciences ; Pharmacology. Drug treatments ; Protein Kinase Inhibitors - chemistry ; Protein Kinase Inhibitors - pharmacology ; Proto-Oncogene Proteins c-met - antagonists & inhibitors ; Quinoline ; Quinolines - pharmacology ; Structure-Activity Relationship</subject><ispartof>European journal of medicinal chemistry, 2008-06, Vol.43 (6), p.1321-1329</ispartof><rights>2007 Elsevier Masson SAS</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3</citedby><cites>FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20412356$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17964000$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kung, Pei-Pei</creatorcontrib><creatorcontrib>Funk, Lee</creatorcontrib><creatorcontrib>Meng, Jerry</creatorcontrib><creatorcontrib>Alton, Gordon</creatorcontrib><creatorcontrib>Padrique, Ellen</creatorcontrib><creatorcontrib>Mroczkowski, Barbara</creatorcontrib><title>Structure activity relationships of quinoline-containing c-Met inhibitors</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>A series of quinoline-containing c-Met inhibitors were prepared and studied. Chemistry was developed to introduce a pyridyl moiety onto the 2-aryl ring present in a lead molecule which mitigated the potential for quinone formation relative to the original compound. The study also assessed the importance of an acylthiourea moiety present in the lead structure for effective binding to the c-Met protein ATP site.
[Display omitted]</description><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>c-Met</subject><subject>General aspects</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Mass Spectrometry</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Kinase Inhibitors - chemistry</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Proto-Oncogene Proteins c-met - antagonists & inhibitors</subject><subject>Quinoline</subject><subject>Quinolines - pharmacology</subject><subject>Structure-Activity Relationship</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kE1rFEEURQtRzCT6D0R6o7tuX333bAQJagIRF-q6qK5-7byhp2pSVR3Iv7fDDLpz9bhw7uVxGHvDoePAzYd9h_sDhl0nAGwHfQecP2Mbbk3fSqHVc7YBIWSrhVQX7LKUPQBoA_CSXXC7NWqNG3b7o-Yl1CVj40OlB6qPTcbZV0qx7OhYmjQ19wvFNFPENqRYPUWKv5vQfsPaUNzRQDXl8oq9mPxc8PX5XrFfXz7_vL5p775_vb3-dNcGuYXa9hYGs1V2UNIMgXvLp34ycrScD0JoEbhFUHY7jbof-oAKQUttufZSWdl7ecXen3aPOd0vWKo7UAk4zz5iWoqz3HAroF9BdQJDTqVknNwx08HnR8fBPSl0e3dS6J4UOujdqnCtvT3vL8MBx3-ls7MVeHcGfAl-nrKPgcpfToDiQmqzch9PHK42HgizK4EwBhwpY6huTPT_T_4A66yQpg</recordid><startdate>20080601</startdate><enddate>20080601</enddate><creator>Kung, Pei-Pei</creator><creator>Funk, Lee</creator><creator>Meng, Jerry</creator><creator>Alton, Gordon</creator><creator>Padrique, Ellen</creator><creator>Mroczkowski, Barbara</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080601</creationdate><title>Structure activity relationships of quinoline-containing c-Met inhibitors</title><author>Kung, Pei-Pei ; Funk, Lee ; Meng, Jerry ; Alton, Gordon ; Padrique, Ellen ; Mroczkowski, Barbara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>c-Met</topic><topic>General aspects</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Mass Spectrometry</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Kinase Inhibitors - chemistry</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Proto-Oncogene Proteins c-met - antagonists & inhibitors</topic><topic>Quinoline</topic><topic>Quinolines - pharmacology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kung, Pei-Pei</creatorcontrib><creatorcontrib>Funk, Lee</creatorcontrib><creatorcontrib>Meng, Jerry</creatorcontrib><creatorcontrib>Alton, Gordon</creatorcontrib><creatorcontrib>Padrique, Ellen</creatorcontrib><creatorcontrib>Mroczkowski, Barbara</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kung, Pei-Pei</au><au>Funk, Lee</au><au>Meng, Jerry</au><au>Alton, Gordon</au><au>Padrique, Ellen</au><au>Mroczkowski, Barbara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure activity relationships of quinoline-containing c-Met inhibitors</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2008-06-01</date><risdate>2008</risdate><volume>43</volume><issue>6</issue><spage>1321</spage><epage>1329</epage><pages>1321-1329</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><coden>EJMCA5</coden><abstract>A series of quinoline-containing c-Met inhibitors were prepared and studied. Chemistry was developed to introduce a pyridyl moiety onto the 2-aryl ring present in a lead molecule which mitigated the potential for quinone formation relative to the original compound. The study also assessed the importance of an acylthiourea moiety present in the lead structure for effective binding to the c-Met protein ATP site.
[Display omitted]</abstract><cop>Oxford</cop><pub>Elsevier Masson SAS</pub><pmid>17964000</pmid><doi>10.1016/j.ejmech.2007.08.011</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0223-5234 |
ispartof | European journal of medicinal chemistry, 2008-06, Vol.43 (6), p.1321-1329 |
issn | 0223-5234 1768-3254 |
language | eng |
recordid | cdi_proquest_miscellaneous_71617208 |
source | ScienceDirect Journals |
subjects | Antineoplastic agents Biological and medical sciences c-Met General aspects Magnetic Resonance Spectroscopy Mass Spectrometry Medical sciences Pharmacology. Drug treatments Protein Kinase Inhibitors - chemistry Protein Kinase Inhibitors - pharmacology Proto-Oncogene Proteins c-met - antagonists & inhibitors Quinoline Quinolines - pharmacology Structure-Activity Relationship |
title | Structure activity relationships of quinoline-containing c-Met inhibitors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T00%3A48%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure%20activity%20relationships%20of%20quinoline-containing%20c-Met%20inhibitors&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Kung,%20Pei-Pei&rft.date=2008-06-01&rft.volume=43&rft.issue=6&rft.spage=1321&rft.epage=1329&rft.pages=1321-1329&rft.issn=0223-5234&rft.eissn=1768-3254&rft.coden=EJMCA5&rft_id=info:doi/10.1016/j.ejmech.2007.08.011&rft_dat=%3Cproquest_cross%3E71617208%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71617208&rft_id=info:pmid/17964000&rfr_iscdi=true |